Crónicas de autores

José A. Barrabés *

Autor invitado por SIIC


VALOR PRONÓSTICO DE LA HIPERTROFIA VENTRICULAR EN EL INFARTO AGUDO DE MIOCARDIO

La hipertrofia ventricular izquierda detectada por electrocardiograma o ecocardiografía puede tener connotaciones pronósticas diferentes en el infarto agudo de miocardio.

*José A. Barrabés
describe para SIIC los aspectos relevantes de su trabajo
USEFULNESS OF ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY TO PREDICT ADVERSE EVENTS IN PATIENTS WITH A FIRST NON-ST-ELEVATION ACUTE MYOCARDIAL INFARCTION
American Journal of Cardiology,
103(4):455-460 Feb, 2009

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*Hospital Universitario Vall D'hebron, Unidad Coronaria, Servicio de Cardiología, Barcelona, España
Imprimir nota
Referencias bibliográficas
Kleiger RE, Boden WE, Schechtman KB, Gibson RS, Schwartz DJ, Geiger BJ, Capone RJ, Roberts R. Frequency and significance of late evolution of Q waves in patients with initial non-Q-wave acute myocardial infarction: Diltiazem Reinfarction Study Group. Am J Cardiol 65:23-27, 1990.
Barrabés JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Q wave evolution of a first acute myocardial infarction without significant ST segment elevation. Int J Cardiol 77:55-62, 2001.
Kannel WB, Gordon T, Castelli WP, Margolis JR. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease: the Framingham Study. Ann Intern Med 72:813-822, 1970.
Levy D, Salomon M, D'Agostino RB, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 90:1786-1793, 194.
Okin PM, Roman MG, Devereux RB, Kligfield P. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol 25:417-423, 1995.
Gertsch M, Theler A, Foglia E. Electrocardiographic detection of left ventricular hypertrophy in the presence of left anterior fascicular block. Am J Cardiol 61:1098-1101, 1988.
Vandenberg B, Sagar K, Paulsen W, Romhilt D. Electrocardiographic criteria for diagnosis of left ventricular hypertrophy in the presence of
complete right bundle branch block. Am J Cardiol 63:1080-1084, 1989.
Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458, 1986.
Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 59:956-960, 1987.
Boden WE, Kleiger RE, Schechtman KB, Capone RJ, Schwartz DJ, Gibson RS; the Diltiazem Reinfarction Study Research Group. Clinical significance and prognostic importance of left ventricular hypertrophy in non-Q-wave acute myocardial infarction. Am J Cardiol 62:1000-1004, 1988.
Behar S, Reicher-Reiss H, Abinader E, Agmon J, Barzilai J, Friedman J, Kaplinsky E, Kauli N, Kishon Y, Palant A, et al; SPRINT Study Group. Long-term prognosis after acute myocardial infarction in patients with left ventricular hypertrophy on the electrocardiogram. Am J Cardiol 69:985-990, 1992.
Yotsukura M, Suzuki J, Yamaguchi T, Sasaki K, Koide Y, Mizuno H, Yoshino H, Ishikawa K. Prognosis following acute myocardial infarction in patients with ECG evidence of left ventricular hypertrophy prior to infarction. J Electrocardiol 31:91-99, 1998.
Goldenberg I, Matetzky S, Hod H, Behar S, Freimark D. Outcome of patients with electrocardiographic evidence of left ventricular hypertrophy following thrombolytic therapy for acute myocardial infarction. Am J Cardiol 88:1024-1026, 2001.
Georgescu A, Fu Y, Yau C, Hassan Q, Luchansky J, Armstrong PW, Wagner G, Van de Werf F, Goodman SG; the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen Trial (ASSENT-3) Investigators. Short- and long-term outcomes of patients with electrocardiographic left ventricular hypertrophy after fibrinolysis for acute myocardial infarction. Am J Cardiol 96:1050-1052, 2005.
Westerhout CM, Lauer MS, James S, Fu Y, Wallentin L, Armstrong PW; the GUSTO IV ACS Investigators. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women. Eur Heart J 28:2064-2069, 2007.
Bolognese L, Dellavesa P, Rossi L, Sarasso G, Bongo AS, Scianaro MC. Prognostic value of left ventricular mass in uncomplicated acute myocardial infarction and one-vessel coronary artery disease. Am J Cardiol 73:1-5, 1994.
Carluccio E, Tommasi S, Bentivoglio M, Buccolieri M, Filippucci L, Prosciutti L, Corea L. Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction. Int J Cardiol 74:177-183, 2000.
Verdecchia P, Carini G, Circo A, Dovellini E, Giovannini E, Lombardo M, Solinas P, Gorini M, Maggioni AP; the MAVI Study Group. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI Study. J Am Coll Cardiol 38:1829-1835, 2001.
Sundström J, Lind L, Arnlöv J, Zethelius B, Andrén B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 103:2346-2351, 2001.
Mayosi BM, Keavney B, Kardos A, Davies CH, Ratcliffe PJ, Farrall M, Watkins H. Electrocardiographic measures of left ventricular hypertrophy show greater heritability than echocardiographic left ventricular mass. Eur Heart J 23:1963-1971, 2002.
Lonn E, Mathew J, Pogue J, Johnstone D, Danisa K, Bosch J, Baird M, Dagenais G, Sleight P, Yusuf S; the Heart Outcomes Prevention Evaluation Study Investigators. Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients. Eur J Cardiovasc Prev Rehabil 10:420-428, 2003.
De Simone G, Gottdiener JS, Chinali M, Maurer MS. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 29:741-747, 2008.
Lauer MS, Martino D, Ishwaran H, Blackstone EH. Quantitative measures of electrocardiographic left ventricular mass, conduction, and repolarization, and long-term survival after coronary artery bypass grafting. Circulation 116:888-893, 2007.
Jiménez-Candil J, Cruz González I, Martín F, Pabón P, León V, Hernández J, Sánchez-Flores M, Moríñigo J, Ledesma C, Martín-Luengo C. Relationship between QRS duration and prognosis in non-ST-segment elevation acute coronary syndrome. Int J Cardiol 126:196-203, 2008.
Elhendy A, Modesto KM, Mahoney DW, Khandheria BK, Seward JB, Pellikka PA. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol 41:129-135, 2003.
Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B, Schnohr P. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave: the Copenhagen City Heart Study. Eur Heart J 23:315-324, 2002.
Larsen GC, Griffith JL, Beshansky JR, D'Agostino RB, Selker HP. Electrocardiographic left ventricular hypertrophy in patients with suspected acute cardiac ischemia-its influence on diagnosis, triage, and short-term prognosis: a multicenter study. J Gen Intern Med 9:666-673, 1994.
Barrabés JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation. J Am Coll Cardiol 35:1813-1819, 2000.
Okin PM, Devereux RB, Nieminen MS, Jern S, Oiakrinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Julius S, Dahlöf B. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE Study. Losartan Intervention For End point. J Am Coll Cardiol 38:514-520, 2001.
Barrabés JA, Figueras J, Moure C, Cortadellas J, Soler-Soler J. Prognostic value of lead aVR in patients with a first non-ST-segment elevation acute myocardial infarction. Circulation 108:814-819, 2003.


ua40317